“Our revenue has grown substantially, and we are proud of the progress we've made in establishing strategic partnerships. The robust pipeline of projects we have in place positions us well for ...

Ginkgo Bioworks (NYSE: DNA) stock has had a rough 12 months, falling 88%, and undergoing a reverse stock split on Aug. 20 that left its shares down by around 18% in the aftermath. Depending on which ...

Get the latest news and real-time alerts from Ginkgo Bioworks Holdings, Inc. (DNA) stock at Seeking Alpha.

Ginkgo Bioworks announces the launch of Ginkgo Datapoints, which aims to make the training of AI models easier and more efficient. Ginkgo Bioworks shares are up more than 9% over the past week. Get 5 ...

To say the past year has been rough for investors in Ginkgo Bioworks (NYSE: DNA) would be an understatement of the highest order. As of Aug 14, shares of the synthetic-biology stock were down by 86% ...

Ginkgo Bioworks continues to face a weak demand environment, which has contributed to a lack of growth in recent years. Learn ...

Ginkgo Bioworks Holdings, Inc. ((DNA)) has held its Q3 earnings call. Read on for the main highlights of the call. Ginkgo Bioworks Holdings, Inc. recently held its earnings call, revealing a mixed ...

A tractor drives across a green field of crops. Ginkgo hopes to develop an alternative to chemical nitrogen fertilizers to help solve pollution issues. Credit: Alamy Ginkgo Bioworks is extending a ...

The average one-year price target for Ginkgo Bioworks Holdings (NYSE:DNA) has been revised to $10.88 / share. This is a ...

Ginkgo Bioworks' market cap has plummeted from more than $25 billion at its peak to less than $600 million at recent prices. The company has announced heaps of layoffs this year in response to heavy ...